Company intelligence / Profile preview

UCEA Capital Partners

London, England, United Kingdomucea.org ↗

Ownership: Private
Development stage: Other

Overview

UCEA Capital Partners is a London-based single-family office and investment firm that specializes in supporting transformative healthcare and technology ventures. It acts as an investor rather than an operator or developer of therapeutics. Its current active investments include several innovative biotech and medtech startups across Europe and the US[2][3][4].

Therapeutic areas: PsychiatryNeurologyInfectious Diseases
Modalities: Small moleculeCombination therapyDevicePCR-based diagnostics platform
Industry: Investors

Partnerships

Lead investor in Wavegate Corporation’s Series A round

Beyond the preview

Go deeper on UCEA Capital Partners.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on UCEA Capital Partners.

Explore the full profile